|
| << previous |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 17 of 17 found articles
| Title: |
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines |
| Author: |
Phillips, Andrew N Bansi-Matharu, Loveleen Venter, Francois Havlir, Diane Pozniak, Anton Kuritzkes, Daniel R Wensing, Annemarie Lundgren, Jens D Pillay, Deenan Mellors, John Cambiano, Valentina Jahn, Andreas Apollo, Tsitsi Mugurungi, Owen Ripin, David Da Silva, Juliana Raizes, Elliot Ford, Nathan Siberry, George K Gupta, Ravindra K Barnabas, Ruanne Revill, Paul Cohn, Jennifer Calmy, Alexandra Bertagnolio, Silvia |
| Appeared in: |
The Lancet. HIV |
| Paging: | Volume 7 () nr. 3 pages e193-e200 |
| Year: |
2020 |
| Contents: | |
| Publisher: |
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 17 of 17 found articles
| << previous |